NL-OMON35874已完成不适用
A Phase Ib, double-blind, randomized, placebo-controlled trial in genotype 1 HCV-infected patients to determine the safety, tolerability, pharmacokinetics and antiviral activity of repeated doses of TMC649128 given as monotherapy and given in combination with pegylated interferon + ribavirin - TMC649128/interferon/ribavirin in HCV patients
PRA International EDS0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Hepatitis C infected patients
- •18-65 year
- •BMI 18.0 - 35.0 kg/m2
排除标准
- •positive for Hepatitis B or HIV
- •except from hepatitis C infection diagnosed as not-healthy
研究者
相似试验
已完成
1 期
A blinded study in healthy volunteers to evaluate the safety of the test medicine and compare how the test medicine behaves when the dosage is increased, and when taken alone or alongside salbutamol (albuterol)Cystic fibrosis (CF)Nutritional, Metabolic, EndocrineCystic fibrosisISRCTN30841680F. Hoffman-La Roche Ltd.41
进行中（未招募）
1 期
A study to evaluate safety and processing by body of GDC-6988 in healthy adults receiving albuterol as a pretreatment medicatioSafety and pharmacokinetics of multiple ascending doses of GDC-6988 with and without albuterol pretreatment in healthy adult subjectsISRCTN15406513F. Hoffmann-La Roche Ltd30
进行中（未招募）
不适用
A clinical trial of antibody GSK1070806 in the treatment of patients with moderate to severe Crohn’s diseaseCrohn's diseaseISRCTN11093445niversity of Birmingham5
已完成
不适用
A phase 1b, randomized, double-blinded, placebo-controlled study of hydroxychloroquine in outpatient adults with COVID-19CoronaCOVID-1910047438NL-OMON49040Sanofi-aventis20
招募中
2 期
A phase IIb, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of Astegolimab in patients with chronic obstructive pulmonary disease.J44 Other chronic obstructive pulmonary diseaseOther chronic obstructive pulmonary diseasePER-066-21GENENTECH, INC.23